Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2008-11-21 to 2009-01-13
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: according to OECD guideline 423 performed under GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-hydroxybenzoic acid
EC Number:
202-804-9
EC Name:
4-hydroxybenzoic acid
Cas Number:
99-96-7
Molecular formula:
C7H6O3
IUPAC Name:
4-hydroxybenzoic acid
Details on test material:
Sponsors Batch No.: 08/1000/10,1-20
production date: 20.10.2008
purity: 99,94%
colour: white
form: powder
storage: protected from light and moisture at room temperature
CAS: 99-96-7
name of testitem (Sponsor's identification): p-Hydroxybenzoesäure
Expiry date: October 2011

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
group 1: one female rat
group 2: six female rats, tested in two groups of three rats
- Source: Elevage JANVIER (53940 Le Genest St Isle - France)
-The rats were eight weeks old, weighed between 178-212g and were housed according to guideline conditions.
- Acclimation period: at least 5 days

Their body weight was determined on day 0, 2, 7 and 14 of the examination procedure. Observations on behavior and mortality were done every day
a systematic examination was carried out on day 14. Except of day one on which food access was allowed 4 hours after test item administration,
Food and drinking water was accessible freely throughout the whole period.
A periodic cycle of continuous light (12 hours) and dark (12 hours ) was guarenteed and a temperature between 19 and 25°C.
Humidity was 30-70 % rel Humidity. The animals were kept in groups of three animals in a clear polycarbonate cage, which was filled with sawdust on the bottom, which was cleaned at least twice a week.

Administration / exposure

Route of administration:
other: syringe and oral administration
Vehicle:
DMSO
Details on oral exposure:
The test item was dissolved in dimethyl sulfoxide (DMSO) and the respective doses were administered by gavage in a volume of 10ml/kg b.w.
Doses:
group1: 5000 mg/kg b.w.
group2: 2000 mg/kg b.w.
No. of animals per sex per dose:
1 female rat at 5000 mg/kg b.w.
6 female animals at 2000 mg/kg b.w. in 2 groups with 3 animals
Control animals:
other: Observations were compared to control data. It is not clearly stated if control animals were observed simultaneously besides treatments.
Details on study design:
one pre-test with one female using 5000 mg/kg. b.w. as dose finding
study then with two groups of three female rats using 2000 mg/kg b.w.
Statistics:
not applicable, results and findings for each animal noted

Results and discussion

Preliminary study:
At 5000 mg/kg b.w. the rat died 2h 45min after administration. It was noted: thickening of the corpus , thinning of the forestomach, white particles in the stomach, grey-brown adherences in stomach , duodenum and jejunum
Effect levelsopen allclose all
Key result
Sex:
female
Dose descriptor:
discriminating dose
Effect level:
5 000 mg/kg bw
Remarks on result:
other: pretest: the female rat died ca. 3h after the oral administration
Key result
Sex:
female
Dose descriptor:
discriminating dose
Effect level:
>= 2 000 mg/kg bw
Remarks on result:
other: 2 groups of 3 female rats, no signs of toxicity
Mortality:
no mortality at 2000 mg/kg b.w.
Clinical signs:
other: no clinical signs at 2000 mg/kg b.w.
Gross pathology:
no abnormal findings at 2000 mg/kg b.w.
Other findings:
no macroscopically observable findings at 2000 mg/kg b.w.

Any other information on results incl. tables

In an acute oral dose-range finding toxicity study 1 female Sprague Dawley rat wasgiven a single oral dose of 4 -HBA of 5000  mg/kg bw. in 10 ml/kg bw. DMSO. Death was observed within 3 hours after administration.

In the following main study 2 groups of 3 female Sprague Dawley rats were given a single oral dose of 2000  mg/kg bw and observed every day for 14 days.

Oral LD50Females = higher than 2000  mg/kg bw.

No clinical signs related to the administration of the test item at 2000 mg/kg bw were observed.

The body weight evolution of the animals treated at 2000 mg/kg bw remained normal throughout the study and no treatment-related changes were revealed through macroscopical examination of the animals.

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The LD50 of the test substance p-Hydroxybenzoic acid is greater than 2000 mg/kg.
At 5000 mg/kg b.w. mortality occurs (pre-test with one animal)
Therefore p-Hydroxybenzoic acid does not have to be classified in category 4 according to EU-GHS criteria.
Executive summary:

In an acute oral toxicity study, in a first step 1 female Sprague Dawley rat was given a single oral dose of p-hydroxybenzoic acid at a dose of 5000  mg/kg bw. Death was observed within 3 hours after test item administration.

In a second step a group of 6 female Sprague Dawley rats were given a single oral dose of p-hydroxybenzoic acid at a dose of 2000  mg/kg bw and observed every day for 14 days.

Oral LD50Females = higher than 2000  mg/kg bw.

No clinical signs related to the administration of the test item at 2000 mg/kg bw were observed. The body weight evolution of the animals treated at 2000 mg/kg bw remained normal throughout the study and no treatment-related changes were revealed through macroscopical examination of the animals.